Summary

Technavio Announces the Publication of its Research Report - Global Topical Corticosteroids Market 2023-2027
Technavio recognizes the following companies as the key players in the global topical corticosteroids market: AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..
Commenting on the report, an analyst from Technavio said: "The latest trend gaining momentum in the market is growing adoption of generic drugs."
According to the report, one of the major drivers for this market is the advancements in drug delivery systems.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/topical-corticosteroids-market-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.technavio.com/industries/pharmaceuticals
Follow us on Twitter @Technavio

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global topical corticosteroids market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global topical corticosteroids market 2017 - 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
o 6.4 Dermatology clinics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Dermatology clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Dermatology clinics - Year-over-year growth 2022-2027 (%)
o 6.5 Pharmacies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by End-user
o Exhibit 50: Market opportunity by End-user ($ million)
o Exhibit 51: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 52: Chart on Type - Market share 2022-2027 (%)
o Exhibit 53: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 54: Chart on Comparison by Type
o Exhibit 55: Data Table on Comparison by Type
o 7.3 Prescription - Market size and forecast 2022-2027
o Exhibit 56: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Prescription - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
o 7.4 OTC - Market size and forecast 2022-2027
o Exhibit 60: Chart on OTC - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on OTC - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on OTC - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Russia - Market size and forecast 2022-2027
o Exhibit 91: Chart on Russia - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Russia - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Russia - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Russia - Year-over-year growth 2022-2027 (%)
o 9.9 Saudi Arabia - Market size and forecast 2022-2027
o Exhibit 95: Chart on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Saudi Arabia - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Saudi Arabia - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Astellas Pharma Inc.
o Exhibit 119: Astellas Pharma Inc. - Overview
o Exhibit 120: Astellas Pharma Inc. - Product / Service
o Exhibit 121: Astellas Pharma Inc. - Key news
o Exhibit 122: Astellas Pharma Inc. - Key offerings
o 12.5 AstraZeneca PLC
o Exhibit 123: AstraZeneca PLC - Overview
o Exhibit 124: AstraZeneca PLC - Product / Service
o Exhibit 125: AstraZeneca PLC - Key news
o Exhibit 126: AstraZeneca PLC - Key offerings
o 12.6 Bausch Health Co. Inc.
o Exhibit 127: Bausch Health Co. Inc. - Overview
o Exhibit 128: Bausch Health Co. Inc. - Business segments
o Exhibit 129: Bausch Health Co. Inc. - Key news
o Exhibit 130: Bausch Health Co. Inc. - Key offerings
o Exhibit 131: Bausch Health Co. Inc. - Segment focus
o 12.7 Bayer AG
o Exhibit 132: Bayer AG - Overview
o Exhibit 133: Bayer AG - Business segments
o Exhibit 134: Bayer AG - Key news
o Exhibit 135: Bayer AG - Key offerings
o Exhibit 136: Bayer AG - Segment focus
o 12.8 Eli Lilly and Co.
o Exhibit 137: Eli Lilly and Co. - Overview
o Exhibit 138: Eli Lilly and Co. - Product / Service
o Exhibit 139: Eli Lilly and Co. - Key news
o Exhibit 140: Eli Lilly and Co. - Key offerings
o 12.9 Galderma SA
o Exhibit 141: Galderma SA - Overview
o Exhibit 142: Galderma SA - Product / Service
o Exhibit 143: Galderma SA - Key news
o Exhibit 144: Galderma SA - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc - Overview
o Exhibit 146: GlaxoSmithKline Plc - Business segments
o Exhibit 147: GlaxoSmithKline Plc - Key news
o Exhibit 148: GlaxoSmithKline Plc - Key offerings
o Exhibit 149: GlaxoSmithKline Plc - Segment focus
o 12.11 Glenmark Pharmaceuticals Ltd.
o Exhibit 150: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 151: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 152: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.12 LEO Pharma AS
o Exhibit 153: LEO Pharma AS - Overview
o Exhibit 154: LEO Pharma AS - Business segments
o Exhibit 155: LEO Pharma AS - Key offerings
o Exhibit 156: LEO Pharma AS - Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 157: Merck and Co. Inc. - Overview
o Exhibit 158: Merck and Co. Inc. - Business segments
o Exhibit 159: Merck and Co. Inc. - Key news
o Exhibit 160: Merck and Co. Inc. - Key offerings
o Exhibit 161: Merck and Co. Inc. - Segment focus
o 12.14 Novartis AG
o Exhibit 162: Novartis AG - Overview
o Exhibit 163: Novartis AG - Business segments
o Exhibit 164: Novartis AG - Key offerings
o Exhibit 165: Novartis AG - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 166: Pfizer Inc. - Overview
o Exhibit 167: Pfizer Inc. - Product / Service
o Exhibit 168: Pfizer Inc. - Key news
o Exhibit 169: Pfizer Inc. - Key offerings
o 12.16 Sanofi SA
o Exhibit 170: Sanofi SA - Overview
o Exhibit 171: Sanofi SA - Business segments
o Exhibit 172: Sanofi SA - Key news
o Exhibit 173: Sanofi SA - Key offerings
o Exhibit 174: Sanofi SA - Segment focus
o 12.17 Viatris Inc.
o Exhibit 175: Viatris Inc. - Overview
o Exhibit 176: Viatris Inc. - Business segments
o Exhibit 177: Viatris Inc. - Key news
o Exhibit 178: Viatris Inc. - Key offerings
o Exhibit 179: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 180: Inclusions checklist
o Exhibit 181: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 182: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 183: Research methodology
o Exhibit 184: Validation techniques employed for market sizing
o Exhibit 185: Information sources
o 13.5 List of abbreviations
o Exhibit 186: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global topical corticosteroids market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Dermatology clinics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Dermatology clinics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Dermatology clinics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by End-user ($ million)
Exhibits51: Data Table on Market opportunity by End-user ($ million)
Exhibits52: Chart on Type - Market share 2022-2027 (%)
Exhibits53: Data Table on Type - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Type
Exhibits55: Data Table on Comparison by Type
Exhibits56: Chart on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Prescription - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Prescription - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on OTC - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on OTC - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on OTC - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on OTC - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Russia - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Russia - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Russia - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Russia - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Saudi Arabia - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Saudi Arabia - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Saudi Arabia - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Astellas Pharma Inc. - Overview
Exhibits120: Astellas Pharma Inc. - Product / Service
Exhibits121: Astellas Pharma Inc. - Key news
Exhibits122: Astellas Pharma Inc. - Key offerings
Exhibits123: AstraZeneca PLC - Overview
Exhibits124: AstraZeneca PLC - Product / Service
Exhibits125: AstraZeneca PLC - Key news
Exhibits126: AstraZeneca PLC - Key offerings
Exhibits127: Bausch Health Co. Inc. - Overview
Exhibits128: Bausch Health Co. Inc. - Business segments
Exhibits129: Bausch Health Co. Inc. - Key news
Exhibits130: Bausch Health Co. Inc. - Key offerings
Exhibits131: Bausch Health Co. Inc. - Segment focus
Exhibits132: Bayer AG - Overview
Exhibits133: Bayer AG - Business segments
Exhibits134: Bayer AG - Key news
Exhibits135: Bayer AG - Key offerings
Exhibits136: Bayer AG - Segment focus
Exhibits137: Eli Lilly and Co. - Overview
Exhibits138: Eli Lilly and Co. - Product / Service
Exhibits139: Eli Lilly and Co. - Key news
Exhibits140: Eli Lilly and Co. - Key offerings
Exhibits141: Galderma SA - Overview
Exhibits142: Galderma SA - Product / Service
Exhibits143: Galderma SA - Key news
Exhibits144: Galderma SA - Key offerings
Exhibits145: GlaxoSmithKline Plc - Overview
Exhibits146: GlaxoSmithKline Plc - Business segments
Exhibits147: GlaxoSmithKline Plc - Key news
Exhibits148: GlaxoSmithKline Plc - Key offerings
Exhibits149: GlaxoSmithKline Plc - Segment focus
Exhibits150: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits151: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits152: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits153: LEO Pharma AS - Overview
Exhibits154: LEO Pharma AS - Business segments
Exhibits155: LEO Pharma AS - Key offerings
Exhibits156: LEO Pharma AS - Segment focus
Exhibits157: Merck and Co. Inc. - Overview
Exhibits158: Merck and Co. Inc. - Business segments
Exhibits159: Merck and Co. Inc. - Key news
Exhibits160: Merck and Co. Inc. - Key offerings
Exhibits161: Merck and Co. Inc. - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Pfizer Inc. - Overview
Exhibits167: Pfizer Inc. - Product / Service
Exhibits168: Pfizer Inc. - Key news
Exhibits169: Pfizer Inc. - Key offerings
Exhibits170: Sanofi SA - Overview
Exhibits171: Sanofi SA - Business segments
Exhibits172: Sanofi SA - Key news
Exhibits173: Sanofi SA - Key offerings
Exhibits174: Sanofi SA - Segment focus
Exhibits175: Viatris Inc. - Overview
Exhibits176: Viatris Inc. - Business segments
Exhibits177: Viatris Inc. - Key news
Exhibits178: Viatris Inc. - Key offerings
Exhibits179: Viatris Inc. - Segment focus
Exhibits180: Inclusions checklist
Exhibits181: Exclusions checklist
Exhibits182: Currency conversion rates for US$
Exhibits183: Research methodology
Exhibits184: Validation techniques employed for market sizing
Exhibits185: Information sources
Exhibits186: List of abbreviations